Jul 5, 2023· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-N-1585-0031
The attached is submitted on behalf of the Consumer Healthcare Products Association (CHPA) on Monday, July 3, 2023.
FDANonrulemakingFDA-2023-N-1585
Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities in Human Drug Products; Establishment of a Public Docket; Request for Comments
RIN
—
Last modified
Jul 7, 2023
Comment window
closed 1121d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jul 5, 2023 and Jul 5, 2023. 2 other organizations filed here. The comment window closed 1121d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
CLOSED
View on regulations.gov →Co-filers (2)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%